Calix, Inc. CALX
Set alert
36.13 USD 0.00 0.00%
At close
35.50 -0.63 -1.74%
Pre-market · Nov 3, 7:45 AM ET
34.97 Day range 37.66
32.35 52-week range 68.19
- YTD
- -31.74%
- 1 year
- -47.19%
- Open
- 37.27
- Prev close
- 36.13
- Mkt cap
- 2.27B
- Vol
- 1.74M
- Avg vol
- 971.19K
- EPS
- 0.75
- P/E
- 48.17
- Div yield
- 0.00%
More statistics
- Low
- 34.97
- High
- 37.66
- Forward P/E
- 15.72
- Beta
- 1.22
- Short ratio
- 4.57
- Inst. own
- 99.35%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 27, 2027
- 50-d avg
- 36.19
- 200-d avg
- 42.55
- 1y target
- 62.33
Analyst view
Consensus: none
Price target (mean) 62.33 +72.5% upside
Now 36.13
- Target (low)
- 52.00
- Target (mean)
- 62.33
- Target (high)
- 85.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy2
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.41129 | 0.37 – 0.42904 | 0.44 | -6.5% | 304.10M | +14.6% | 7 |
| Next quarter | 0.44527 | 0.4069 – 0.50 | 0.39 | +14.2% | 314.19M | +15.3% | 7 |
| Current year | 1.72 | 1.64 – 1.78 | 1.35 | +27.5% | 1.19B | +19.1% | 7 |
| Next year | 2.30 | 1.90 – 2.60 | 1.72 | +33.7% | 1.38B | +15.6% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 23, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jul 22, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Northland Capital Markets | Upgrade | Market Perform | Outperform |
| Jul 21, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jun 10, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Apr 23, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Apr 23, 2026 | Needham | Maintained | Buy | Buy |
| Apr 22, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 22, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Apr 16, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 31, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jan 30, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jan 30, 2026 | Needham | Maintained | Buy | Buy |
| Jan 27, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Jan 15, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Nov 24, 2025 | Needham | Reiterated | Buy | Buy |
| Oct 31, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 31, 2025 | Rosenblatt | Maintained | Buy | Buy |
| Oct 31, 2025 | Needham | Maintained | Buy | Buy |
| Sep 15, 2025 | Roth Capital | Maintained | Buy | Buy |
| Jul 23, 2025 | Rosenblatt | Maintained | Buy | Buy |
| Jul 22, 2025 | Needham | Maintained | Buy | Buy |
| Jul 22, 2025 | Rosenblatt | Maintained | Buy | Buy |
| Jul 17, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 15, 2025 | Rosenblatt | Maintained | Buy | Buy |
| Jul 8, 2025 | Wolfe Research | Initiated | — | Peer Perform |
| Jun 12, 2025 | Rosenblatt | Maintained | Buy | Buy |
| Apr 23, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 23, 2025 | Rosenblatt | Maintained | Buy | Buy |
| Apr 23, 2025 | Needham | Reiterated | Buy | Buy |
